Healthcare industry leaders to provide clinical guidance for ongoing evolution of BodyGuardian Remote Monitoring System and remote monitoring capabilities
MINNEAPOLIS (October 3, 2013) Preventice®, Inc., a leader in remote patient monitoring technology, announced today the appointment of a medical advisory board. The company tapped recognized leaders in clinical cardiology, patient monitoring technology, health sciences and nursing to guide the evolution of remote monitoring solutions, including the BodyGuardian® Remote Monitoring System, and to provide insight into the clinical needs of physicians, patients and life sciences companies.
“Preventice and the BodyGuardian are grounded in a mission to meet real-life clinical needs. Remote monitoring systems like BodyGuardian address the desire for technology that improves outcomes and saves money, without interrupting a patient’s normal daily activities or affecting their quality of life,” said Jon Otterstatter, co-founder, president and CEO of Preventice. “The medical advisory board will keep Preventice in touch with the changing needs of the professionals who prescribe and use the BodyGuardian, and the patients who benefit from this technology.”